91 related articles for article (PubMed ID: 23091618)
1. Critical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based research.
Xie XB; Yin JQ; Wen LL; Gao ZH; Zou CY; Wang J; Huang G; Tang QL; Colombo C; He WL; Jia Q; Shen JN
PLoS One; 2012; 7(10):e47375. PubMed ID: 23091618
[TBL] [Abstract][Full Text] [Related]
2. Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.
Musiani D; Konda JD; Pavan S; Torchiaro E; Sassi F; Noghero A; Erriquez J; Perera T; Olivero M; Di Renzo MF
FASEB J; 2014 Sep; 28(9):4055-67. PubMed ID: 24903273
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated Hsp27 promotes adriamycin resistance in breast cancer cells through regulating dual phosphorylation of c-Myc.
Bi X; Zhang M; Zhou J; Yan X; Cheng L; Luo L; Huang C; Yin Z
Cell Signal; 2023 Dec; 112():110913. PubMed ID: 37797796
[TBL] [Abstract][Full Text] [Related]
4. Heat Shock Protein HSP27 and the Status of the Glutathione System in Dexamethasone-Induced Apoptosis of Jurkat Tumor Cells.
Nosareva OL; Stepovaya EA; Litvinova LS; Yurova KA
Bull Exp Biol Med; 2024 Mar; 176(5):617-619. PubMed ID: 38730108
[TBL] [Abstract][Full Text] [Related]
5. Effects of low-dose bufalin combined with hydroxycamptothecin on human castration-resistant prostate cancer xenografts in nude mice.
Gu R; Zhang Q
Exp Ther Med; 2021 Sep; 22(3):1015. PubMed ID: 34373701
[TBL] [Abstract][Full Text] [Related]
6. GEM-Based Metabolic Profiling for Human Bone Osteosarcoma under Different Glucose and Glutamine Availability.
Weglarz-Tomczak E; Rijlaarsdam DJ; Tomczak JM; Brul S
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540580
[TBL] [Abstract][Full Text] [Related]
7. Chemistry and the Potential Antiviral, Anticancer, and Anti-Inflammatory Activities of Cardiotonic Steroids Derived from Toads.
El-Seedi HR; Yosri N; El-Aarag B; Mahmoud SH; Zayed A; Du M; Saeed A; Musharraf SG; El-Garawani IM; Habib MR; Tahir HE; Hegab MM; Zou X; Guo Z; Efferth T; Khalifa SAM
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235123
[TBL] [Abstract][Full Text] [Related]
8. Development of a hybrid peptide dendrimer micellar carrier system and its application in the reformulation of a hydrophobic therapeutic agent derived from traditional Chinese medicine.
Jing J; Tupally KR; Kokil GR; Qu Z; Chen S; Parekh HS
RSC Adv; 2019 Jan; 9(5):2458-2463. PubMed ID: 35520530
[TBL] [Abstract][Full Text] [Related]
9. Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma.
Chen R; Guan Z; Zhong X; Zhang W; Zhang Y
Comput Math Methods Med; 2022; 2022():3197402. PubMed ID: 35069780
[TBL] [Abstract][Full Text] [Related]
10. Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues.
Lallier M; Marchandet L; Moukengue B; Charrier C; Baud'huin M; Verrecchia F; Ory B; Lamoureux F
Cells; 2021 Mar; 10(4):. PubMed ID: 33808130
[TBL] [Abstract][Full Text] [Related]
11. From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery.
Bordon KCF; Cologna CT; Fornari-Baldo EC; Pinheiro-Júnior EL; Cerni FA; Amorim FG; Anjolette FAP; Cordeiro FA; Wiezel GA; Cardoso IA; Ferreira IG; de Oliveira IS; Boldrini-França J; Pucca MB; Baldo MA; Arantes EC
Front Pharmacol; 2020; 11():1132. PubMed ID: 32848750
[TBL] [Abstract][Full Text] [Related]
12. Bufalin down-regulates Axl expression to inhibit cell proliferation and induce apoptosis in non-small-cell lung cancer cells.
Kim NY; Suh YA; Kim S; Lee C
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32219334
[TBL] [Abstract][Full Text] [Related]
13. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin.
Cheng CS; Wang J; Chen J; Kuo KT; Tang J; Gao H; Chen L; Chen Z; Meng Z
Cancer Cell Int; 2019; 19():92. PubMed ID: 31011289
[TBL] [Abstract][Full Text] [Related]
14. A research update on the anticancer effects of bufalin and its derivatives.
Lan YL; Lou JC; Jiang XW; Wang X; Xing JS; Li S; Zhang B
Oncol Lett; 2019 Apr; 17(4):3635-3640. PubMed ID: 30915168
[TBL] [Abstract][Full Text] [Related]
15. Differential proteomics for studying action mechanisms of traditional Chinese medicines.
Yang YY; Yang FQ; Gao JL
Chin Med; 2019; 14():1. PubMed ID: 30636970
[TBL] [Abstract][Full Text] [Related]
16. Chinese Herbal Medicine for Osteosarcoma in the Mouse: A Systematic Review and Meta-Analysis.
Chang JL; Wang WY; Li YM; Hu SP; Yao M; Cui XJ; Zhi WL; Shi Q; Wang YJ; Yang YP
Chin J Integr Med; 2019 May; 25(5):370-377. PubMed ID: 30484018
[TBL] [Abstract][Full Text] [Related]
17. Bufalin induces DNA damage response under hypoxic condition in myeloma cells.
Fujii E; Inada Y; Kakoki M; Nishimura N; Endo S; Fujiwara S; Wada N; Kawano Y; Okuno Y; Sugimoto T; Hata H
Oncol Lett; 2018 May; 15(5):6443-6449. PubMed ID: 29616114
[TBL] [Abstract][Full Text] [Related]
18. Analysis of HSP27 and the Autophagy Marker LC3B
Livingston JA; Wang WL; Tsai JW; Lazar AJ; Leung CH; Lin H; Advani S; Daw N; Santiago-O'Farrill J; Hollomon M; Gordon NB; Kleinerman ES
Mol Cancer Ther; 2018 Jun; 17(6):1315-1323. PubMed ID: 29592877
[TBL] [Abstract][Full Text] [Related]
19. Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer.
Ji D; Liang Z; Liu G; Zhao G; Fang J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1211-1219. PubMed ID: 28840279
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
